219 related articles for article (PubMed ID: 32815777)
1. Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD.
Hussain S; Khan AW; Akhmedov A; Suades R; Costantino S; Paneni F; Caidahl K; Mohammed SA; Hage C; Gkolfos C; Björck H; Pernow J; Lund LH; Lüscher TF; Cosentino F
Circ Res; 2020 Oct; 127(10):1261-1273. PubMed ID: 32815777
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction.
Paneni F; Osto E; Costantino S; Mateescu B; Briand S; Coppolino G; Perna E; Mocharla P; Akhmedov A; Kubant R; Rohrer L; Malinski T; Camici GG; Matter CM; Mechta-Grigoriou F; Volpe M; Lüscher TF; Cosentino F
Circulation; 2013 Mar; 127(11):1229-40, e1-21. PubMed ID: 23410942
[TBL] [Abstract][Full Text] [Related]
3. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy.
Costantino S; Akhmedov A; Melina G; Mohammed SA; Othman A; Ambrosini S; Wijnen WJ; Sada L; Ciavarella GM; Liberale L; Tanner FC; Matter CM; Hornemann T; Volpe M; Mechta-Grigoriou F; Camici GG; Sinatra R; Lüscher TF; Paneni F
Eur Heart J; 2019 Mar; 40(12):997-1008. PubMed ID: 30629164
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and renal upregulation of Nox2 and NF-
Gajos-Draus A; Duda M; Beręsewicz A
Physiol Rep; 2017 Nov; 5(20):. PubMed ID: 29084841
[TBL] [Abstract][Full Text] [Related]
5. Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts.
Marfella R; D'Onofrio N; Trotta MC; Sardu C; Scisciola L; Amarelli C; Balestrieri ML; Grimaldi V; Mansueto G; Esposito S; D'Amico M; Golino P; Signoriello G; De Feo M; Maiello C; Napoli C; Paolisso G
Metabolism; 2022 Feb; 127():154936. PubMed ID: 34801581
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3.
Akhmedov A; Montecucco F; Costantino S; Vdovenko D; Schaub Clerigué A; Gaul DS; Burger F; Roth A; Carbone F; Liberale L; Amrollahi-Sharifabadi M; Vellone VG; Eriksson U; Matter CM; Crowe LA; Vallée JP; Paneni F; Vanhoutte PM; Camici GG; Mach F; Lüscher TF
Thromb Haemost; 2020 Jan; 120(1):168-180. PubMed ID: 31858519
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via
Lu S; Liao Z; Lu X; Katschinski DM; Mercola M; Chen J; Heller Brown J; Molkentin JD; Bossuyt J; Bers DM
Circ Res; 2020 May; 126(10):e80-e96. PubMed ID: 32134364
[TBL] [Abstract][Full Text] [Related]
8. Oxymatrine Ameliorates Memory Impairment in Diabetic Rats by Regulating Oxidative Stress and Apoptosis: Involvement of NOX2/NOX4.
Huang Y; Li X; Zhang X; Tang J
Oxid Med Cell Longev; 2020; 2020():3912173. PubMed ID: 33273999
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities.
Tan YY; Chen LX; Fang L; Zhang Q
BMC Complement Med Ther; 2020 Dec; 20(1):378. PubMed ID: 33308195
[TBL] [Abstract][Full Text] [Related]
10. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
Shi Q; Lee DY; Féliers D; Abboud HE; Bhat MA; Gorin Y
Mol Metab; 2020 Jun; 36():100968. PubMed ID: 32240965
[TBL] [Abstract][Full Text] [Related]
11. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
[TBL] [Abstract][Full Text] [Related]
12. HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury.
Fan XD; Wan LL; Duan M; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(2):444-451. PubMed ID: 29655790
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66
Costantino S; Paneni F; Mitchell K; Mohammed SA; Hussain S; Gkolfos C; Berrino L; Volpe M; Schwarzwald C; Lüscher TF; Cosentino F
Int J Cardiol; 2018 Oct; 268():179-186. PubMed ID: 30047409
[TBL] [Abstract][Full Text] [Related]
15. FcγR/ROS/CK2α Is the Key Inducer of NF-κB Activation in a Murine Model of Asthma.
Kim JM; Kim HK; Im YN; Bae YS; Im SY; Lee HK
Int Arch Allergy Immunol; 2018; 175(1-2):16-25. PubMed ID: 29339659
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity.
Muñoz M; López-Oliva ME; Rodríguez C; Martínez MP; Sáenz-Medina J; Sánchez A; Climent B; Benedito S; García-Sacristán A; Rivera L; Hernández M; Prieto D
Redox Biol; 2020 Jan; 28():101330. PubMed ID: 31563085
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
[TBL] [Abstract][Full Text] [Related]
19. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-
Liang E; Liu X; Du Z; Yang R; Zhao Y
Oxid Med Cell Longev; 2018; 2018():9086747. PubMed ID: 30046380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
